Cargando…
Valganciclovir as Add-On to Standard Therapy in Secondary Glioblastoma
Patients with glioblastoma have a very poor prognosis despite aggressive therapeutic strategies. Cytomegalovirus has been detected in >90% of glioblastoma tumors. This virus can affect tumor progression and may represent a novel glioblastoma therapy target. We report, here, a retrospective surviv...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599902/ https://www.ncbi.nlm.nih.gov/pubmed/32987955 http://dx.doi.org/10.3390/microorganisms8101471 |